Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medtech Podcasts

Listen to Medtech Insight podcasts for our perspectives on regulation, policy, quality, R&D and key commercial topics.

Navigate to our Medtech podcasts:

Device Week

Medtech Insight reporters and editors offer additional perspective on the biggest medtech news of the week.

Device Week, 13 April 2022 – Highlights From Miach And Outset Exec Chats; Medtronic’s Update On Renal Denervation Trials

In this edition of Device Week, Medtech Insight’s Marion Webb reviews her recent interviews with Martha Shadan, the CEO of Miach Orthopaedics, and Outset Medical’s CEO Leslie Trigg. Reed Miller has an update on Medtronic’s long-awaited renal denervation technology.

Device Week, 1 April 2022 – MDUFA V Heads To Capitol Hill

In this episode of Device Week: US lawmakers grilled FDA device center director Jeff Shuren on 30 March about the agency’s approach to putting together the latest user-fee agreement between industry and FDA.

Device Week, 10 March 2022 – Femtech Attracts Investors; ZimVie Fails To Impress Wall Street

In this edition of Device Week, Medtech Insight’s Barnaby Pickering discusses Zimmer Biomet’s recent spin-off of its spinal and dental businesses under the name ZimVie and editor Marion Webb explains the emerging field of femtech, which includes innovations to treat often-overlooked unmet needs in women’s health

See More Device Week

Speaking Of Medtech

An in-depth podcast series on all things medical devices.

Speaking Of Medtech, Ep. 8: Medical Device Quality

In this episode of Speaking Of Medtech: Too often quality is overshadowed by regulatory and compliance, and some manufacturers view quality as an obstacle to getting product into the marketplace rather than a concept that will help a company save money, reputation, and patient lives.

Speaking Of Medtech, Ep. 7: Real-World Evidence And Data

In this episode of Speaking Of Medtech we’re talking real-world evidence and real-world data – what it is, who’s using it, and why the medtech industry and the US FDA are so keen to collect it.

Speaking Of Medtech, Ep. 6: 2022 Predictions For FDA’s Device Center

In this episode of Speaking Of Medtech we’re breaking out the crystal ball to give a few predictions of what could be in store this year for industry and the US FDA’s Center for Devices and Radiological Health. From the ongoing COVID-19 pandemic to digital devices and facility inspections, there’s a lot of ground to cover.

See More Speaking Of Medtech


Semi-regular features and one-offs.

Digital Health Roundup: AI Trends In Medtech; Exec Chats; FDA’s Digital Health Guru Steps Down

In this roundup feature focusing on new developments in digital health, Medtech Insight spotlights AI trends in medtech, Exec Chats with iRhythm and medical robotics authority Moshe Shoham, and key FDA updates.

Digital Health Roundup: March Mad About Medtech Meetings; Telehealth Legislative Update

In this roundup feature focusing on new developments in digital health, Medtech Insight spotlights conference highlights from HIMSS, AAOS, Sensors Summit and legislative telehealth news.

EU Post-Market Surveillance: How Doing More Than Minimum Will Benefit Medtech Manufacturers

Post-market surveillance requirements apply to all products under the EU’s Medical Device Regulation. Companies would do well to evaluate the additional benefits PMS can offer them, leading devices expert Bassil Akra explained during a recent interview.

See All Medtech Podcasts


Informa Pharma Intelligence podcasts discuss key ideas and insights affecting biopharma and medtech, brought to you by our global team of editors. Listen on-demand to our perspectives on the latest industry developments.



HBW Podcasts